// App-Quantinova.ai

443 : A retrospective single centre study exploring the efficacy of sequential tyrosine kinase inhibitors (TKI) in patients with hepatocellular cancer.

Researchers

Presenter

  • Catherine Roberts

Principal Investigators

  • Phillipa Kaina

  • David Propper

  • Nikolaos Diamantis

  • Rachael Delderfield

  • Alice Karuri

  • Marilyn Reyes

  • Rajinder Nijjar

  • Sarah Slater

Medical Centers

  • IMS Health, London, United Kingdom

  • Guy's Hospital, London, United Kingdom

  • Guy's Hospital, London, United Kingdom

  • Barts Health NHS Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • N/A

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved